|Articles|January 14, 2014

Wingspan Technology Debuts New Version eTMF Next Week

Wingspan Technology will debut its eTMF 2.0 via webcast January 22.

On January 22, Wingspan Technology will launch the next iteration of its eTMF 2.0, which the company says will be a major overhaul. To that end, it will be holding a webinar to demonstrate the product and its capabilities.

A recent survey conducted by Applied Clinical Trials and our conference division, CBI, found thata little less than 25% of the respondents have implemented an eTMF solution. eTMF will have its own track at CBI's upcoming ClinTech 2014 event in March. Wingspan Technology is a sponsor of the event.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

Wingspan Technology Debuts New Version eTMF Next Week

Related Content

ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

How to Tell Substance from Branding in Biotech's Support Ecosystem

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

Trending on Applied Clinical Trials Online

Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters

Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies

ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma

FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership

ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap